Prognostic Markers of Myelodysplastic Syndromes
Myelodysplastic syndrome (MDS) is a clonal disease characterized by multilineage dysplasia, peripheral blood cytopenias, and a high risk of transformation to acute myeloid leukemia. In theory, from clonal hematopoiesis of indeterminate potential to hematologic malignancies, there is a complex interp...
Hlavní autoři: | Yuliya Andreevna Veryaskina, Sergei Evgenievich Titov, Igor Borisovich Kovynev, Tatiana Ivanovna Pospelova, Igor Fyodorovich Zhimulev |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2020-07-01
|
Edice: | Medicina |
Témata: | |
On-line přístup: | https://www.mdpi.com/1648-9144/56/8/376 |
Podobné jednotky
-
The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
Autor: Yuliya Andreevna Veryaskina, a další
Vydáno: (2020-10-01) -
Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
Autor: Chantana Polprasert, a další
Vydáno: (2022-12-01) -
Cytogenetic profile in patients with primary myelodysplastic syndrome
Autor: S V Gritsaev, a další
Vydáno: (2013-07-01) -
The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
Autor: Ying Chen, a další
Vydáno: (2024-12-01) -
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
Autor: Ying Chen, a další
Vydáno: (2023-03-01)